Differential Diagnosis for Acute Upper Abdominal Pain: Considerations and Exclusions

Acute upper abdominal pain can be caused by a variety of conditions, and a thorough differential diagnosis is necessary to determine the underlying cause. In this case, the patient’s history of alcohol abuse is a significant risk factor for acute pancreatitis, which is consistent with the presentation of quick-onset, severe upper abdominal pain with vomiting. Mild pyrexia is also common in acute pancreatitis. However, other conditions must be considered and excluded.

Pulmonary embolism can cause acute pain, but it is typically pleuritic and associated with shortness of breath rather than nausea and vomiting. Aortic dissection is another potential cause of sudden-onset upper abdominal pain, but it is rare under the age of 40 and typically associated with a history of hypertension and smoking. Myocardial infarction should also be on the differential diagnosis, but the location of the pain and radiation to the back, along with the lack of a history of cardiac disease or hypertension, suggest other diagnoses. Nevertheless, an electrocardiogram (ECG) should be performed to exclude myocardial infarction.

Bleeding oesophageal varices can develop as a consequence of portal hypertension, which is usually due to cirrhosis. Although the patient is not known to have liver disease, his history of alcohol abuse is a significant risk factor for cirrhosis. However, bleeding oesophageal varices would present with haematemesis, which the patient does not have.

In conclusion, a thorough differential diagnosis is necessary to determine the underlying cause of acute upper abdominal pain. In this case, acute pancreatitis is the most likely diagnosis, but other conditions must be considered and excluded.

Management of Aphthous Ulcers: Topical Steroids and Pain Control

Aphthous ulcers are a common benign oral lesion that can be triggered by local trauma or certain foods. The first-line management for this condition typically involves topical steroids and topical lidocaine for pain control. Biopsy of the lesion is not indicated unless the ulcer is not healing after three weeks and malignancy needs to be excluded. Epstein-Barr virus testing is only necessary if there are signs of oral hairy leucoplakia. Immediate specialist referral is necessary if there are signs of malignancy. Oral steroids can be considered in refractory cases, but should be used cautiously in patients with diabetes mellitus.

The Child-Turcotte-Pugh score (CTP) is used to assess disease severity in cirrhosis of liver. It consists of five clinical measures, each scored from 1 to 3 according to severity. The minimum score is 5 and maximum score is 15. Once a score has been calculated, the patient is graded A, B, or C for severity. The CTP score is primarily used to decide the need for liver transplantation. However, some criticisms of this scoring system highlight the fact that each of the five categories is given equal weighting, which is not always appropriate. Additionally, in two specific diseases, primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC), the bilirubin cut-off levels in the table are markedly different.

Diagnostic Tests for Acute Pancreatitis

Acute pancreatitis is a condition that is commonly caused by gallstones and alcohol consumption. Its symptoms include upper abdominal pain, nausea, and vomiting. While serum amylase is widely used for diagnosis, serum lipase is preferred where available. Serum lactate is a useful marker for organ perfusion and can indicate the severity of the inflammatory response. A raised white cell count, particularly neutrophilia, is associated with a poorer prognosis. Serum calcium levels may also be affected, but this is not a specific test for pancreatitis. Blood glucose levels may be abnormal, with hyperglycemia being common, but this is not diagnostic of acute pancreatitis.

Reliable Antibody Test for Coeliac Disease

Coeliac disease is an autoimmune condition that targets the gliadin epitope in gluten. It often presents in children with symptoms such as failure to thrive and diarrhoea, which can start during weaning. To diagnose coeliac disease, doctors use antibody tests such as anti-TTG, anti-endomysial antibody, and antigliadin. Among these, anti-TTG is the most reliable and is used as a first-line screening test due to its sensitivity of nearly 100%. Anti-endomysial antibodies are more expensive and observer-dependent, so they are not recommended as a first-line screening test. Antigliadin is rarely measured due to its lower accuracy. It is also important to measure IgA levels because IgA-deficient patients may be asymptomatic and cause a false-negative anti-TTG test.

Autoimmune Conditions and Antibody Tests

Autoimmune conditions can cause a variety of symptoms, including diarrhoea and bloating. Graves’ autoimmune thyroid disease, for example, may present with diarrhoea, but bloating is not commonly associated. To diagnose autoimmune conditions, doctors use antibody tests such as ANCA, which is raised in many autoimmune conditions, including some patients with ulcerative colitis. However, ANCA is not raised in coeliac disease. Therefore, it is important to use the appropriate antibody test for each autoimmune condition to ensure an accurate diagnosis.

Understanding Risk Factors for Oesophageal Cancer

Oesophageal cancer is a type of cancer that is becoming increasingly common. It often presents with symptoms such as dysphagia, weight loss, and retrosternal chest pain. Adenocarcinomas, which are the most common type of oesophageal cancer, typically develop in the lower third of the oesophagus due to inflammation related to gastric reflux.

One of the risk factors for oesophageal cancer is Barrett’s oesophagus, which is the metaplasia of the squamous epithelium of the lower oesophagus when exposed to an acidic environment. This adaptive change significantly increases the risk of malignant change. Treatment options for Barrett’s oesophagus include ablative or excisional therapy and acid-lowering medications. Follow-up with repeat endoscopy every 2–5 years is required.

Blood group A is not a risk factor for oesophageal cancer, but it is associated with a 20% higher risk of stomach cancer compared to those with blood group O. A diet low in calcium is also not a risk factor for oesophageal carcinoma, but consumption of red meat is classified as a possible cause of oesophageal cancer. Those with the highest red meat intake have a 57% higher risk of oesophageal squamous cell carcinoma compared to those with the lowest intake.

Ulcerative colitis is not a risk factor for oesophageal cancer, but it is a risk factor for bowel cancer. On the other hand, alcohol is typically a risk factor for squamous cell carcinomas. Understanding these risk factors can help individuals take steps to reduce their risk of developing oesophageal cancer.

The only definitive treatment for advanced hepatic disease in primary sclerosing cholangitis (PSC) is orthotopic liver transplantation (OLT). Patients with intractable pruritus and recurrent bacterial cholangitis are specifically indicated for transplant. Although there is a 25-30% recurrence rate in 5 years, outcomes following transplant are good, with an 80-90% 5-year survival rate. PSC has become the second most common reason for liver transplantation in the United Kingdom. Other treatments such as steroids, azathioprine, methotrexate, and pentoxifylline have not been found to be useful. Antibiotic prophylaxis with ciprofloxacin or co-trimoxazole can be used to treat bacterial ascending cholangitis, but it will not alter the natural course of the disease.

Differential Diagnosis for a Patient with Elevated Bilirubin Levels

One possible cause of elevated bilirubin levels is Gilbert syndrome, an autosomal recessive condition that results in a deficiency of glucuronyl transferase activity. This condition leads to an increase in unconjugated bilirubin levels, which can become more pronounced during periods of fasting or illness. Treatment for Gilbert syndrome is not necessary, and the prognosis is excellent without significant long-term effects.

Hepatitis A is another possible cause of elevated bilirubin levels, particularly in individuals who have traveled to areas where the virus is common or who have occupational exposure to contaminated materials. Symptoms of hepatitis A include flu-like symptoms, anorexia, nausea, vomiting, and malaise, followed by acute hepatitis with jaundice, pale stools, and dark urine. However, the absence of risk factors and normal alanine aminotransferase levels make hepatitis A unlikely.

Infectious mononucleosis, caused by the Epstein-Barr virus, can also cause elevated bilirubin levels. Symptoms typically include acute tonsillitis and flu-like symptoms, as well as viral hepatitis. However, the absence of upper respiratory tract infection symptoms, normal ALT levels, and the lack of lymphocytosis make this diagnosis unlikely.

Autoimmune hemolysis is another possible cause of elevated bilirubin levels, but normal hemoglobin and lactate dehydrogenase levels make this diagnosis unlikely.

Hepatitis B is a viral infection that is primarily transmitted through sexual contact and intravenous drug use. Symptoms include acute hepatitis with jaundice, and chronic infection can develop in some cases. However, normal ALT levels and the absence of risk factors make this diagnosis unlikely.

Location of Gastric Cancers: Changing Trends

Gastric cancers can arise from different parts of the stomach, including the cardia, body, fundus, antrum, and pylorus. In the past, the majority of gastric cancers used to originate from the antrum and pylorus. However, in recent years, there has been a shift in the location of gastric cancers, with the majority now arising from the cardia. This change in trend highlights the importance of ongoing research and surveillance in the field of gastric cancer.

Appropriate Management for a Patient with Dysphagia and ‘Alarm’ Symptoms

When a patient presents with dysphagia and ‘alarm’ symptoms such as weight loss, anorexia, and swallowing difficulties, prompt referral for an urgent endoscopy is necessary. In the case of a patient with a significant smoking history, male sex, and alcohol intake, there is a high suspicion for oesophageal cancer, and an immediate referral to an upper gastrointestinal surgeon is required under the 2-week-wait rule.

Continuing treatment with over-the-counter medications like Gaviscon would be inappropriate in this case, as would histamine-2 receptor antagonist therapy. Oesophageal manometry would only be indicated if the patient had an oesophageal motility disorder. Proton-pump inhibitor (PPI) therapy can be initiated in patients with gastroesophageal reflux disease, but it would not be appropriate as a sole treatment option for a patient with clinical manifestations concerning for oesophageal carcinoma.

In summary, prompt referral for an urgent endoscopy is crucial for patients with dysphagia and ‘alarm’ symptoms, and appropriate management should be tailored to the individual patient’s clinical presentation.

The patient’s symptoms and lab results suggest that they have acute pancreatitis, which is commonly seen in individuals with alcoholism or gallstone disease. This condition is characterized by severe epigastric pain that may radiate to the back, and an increase in pancreatic enzymes like amylase within 6-12 hours of onset. Lipase levels can also aid in diagnosis, as they rise earlier and last longer than amylase levels. Acute mesenteric ischemia, perforated peptic ulcer, pyelonephritis, and small bowel obstruction are less likely diagnoses based on the patient’s symptoms and medical history.

Obscure gastrointestinal bleeding can be either overt or occult, without clear cause identified by invasive tests. Video capsule endoscopy has become the preferred method of diagnosis, with other methods such as nuclear scans and push endoscopy being used less frequently. Small bowel angiography may be used after capsule endoscopy to treat an identified bleeding point. However, not all suspicious-looking vascular lesions are the cause of bleeding, so angiography is necessary to confirm the actively bleeding lesion. Wireless capsule endoscopy is contraindicated in patients with swallowing disorders, suspected small bowel stenosis, strictures or fistulas, those who require urgent MRI scans, and those with gastroparesis. Scintiscan involves the use of radiolabelled markers to detect points of bleeding in the GI tract. Double balloon endoscopy is a specialist technique that allows for biopsy and local treatment of abnormalities detected in the small bowel, but it is time-consuming and requires prolonged sedation or general anesthesia. Blind biopsy of the duodenum may be considered if all other tests are negative.

Diaphragmatic Hiatal Hernia

Diaphragmatic hiatal hernia is a condition where the fundus or gastro-oesophageal junction of the stomach herniates upwards in the chest due to an abnormal defect in the diaphragm. A chest X-ray may reveal gastric air and fluid behind the mediastinum, and reduced air entry at the lung bases due to compression of the lung lobes. Immediate management involves stabilizing the patient with ABCDE and seeking an urgent surgical review for a possible Nissen fundoplication.

Other conditions such as early cholangitis, aspiration pneumonia of the left lower lobe of the lung, ruptured left ventricle, or ruptured right ventricle may present with different symptoms and would not cause the air and fluid level behind the mediastinum seen in diaphragmatic hiatal hernia.

Gastrin-Secreting Tumors: Locations and Diagnosis

Gastrin-secreting tumors, also known as gastrinomas, are rare and often associated with multiple endocrine neoplasia type 1 (MEN1) syndrome. These tumors cause excessive gastrin levels, leading to high levels of acid in the stomach and multiple refractory gastric ulcers. The majority of gastrinomas are found in the head of the pancreas or proximal duodenum, with around 20-30% being malignant.

Clinical features of gastrinomas are similar to peptic ulceration, including severe epigastric pain, blood-stained vomiting, melaena, or perforation. A diagnosis of gastrinoma should prompt further work-up to exclude MEN1. The key investigation is the finding of elevated fasting serum gastrin, ideally sampled on three separate days to definitively exclude a gastrinoma.

If a gastrinoma is confirmed, tumor location is ideally assessed by endoscopic ultrasound. CT of the thorax, abdomen, and pelvis, along with OctreoScan®, are used to stage the tumor. If the tumor is localized, surgical resection is curative. Otherwise, aggressive proton pump inhibitor therapy and octreotide offer symptomatic relief.

While the vast majority of gastrinomas are found in the pancreas and duodenum, rare ectopic locations such as the kidney, heart, and liver can also occur. It is important to consider gastrinomas in the differential diagnosis of peptic ulceration and to perform appropriate diagnostic work-up to ensure prompt and effective treatment.

Differentiating Autoimmune Liver Disease: Antibody Tests

When a patient presents with abnormal liver function tests and a young age, autoimmune liver disease is a possible diagnosis. To confirm this, the most specific antibody test is for anti-smooth muscle antibodies, which are positive in about 80% of patients with autoimmune liver disease.

On the other hand, anti-mitochondrial antibodies are the hallmark of primary biliary cholangitis, with over 95% of patients being subtype M2 positive. Hepatitis A IgM antibodies are elevated in patients with acute hepatitis A infection, but not in autoimmune liver disease.

While raised anti-nuclear antibodies (ANAs) are seen in many autoimmune conditions, they are not very specific for autoimmune hepatitis. Positive ANAs are also seen in other diseases like systemic sclerosis, rheumatoid arthritis, and Sjögren syndrome. Similarly, anti-Smith antibodies are seen in about 20% of patients with systemic lupus erythematosus but are not specific for autoimmune liver disease.

In conclusion, antibody tests play a crucial role in differentiating autoimmune liver disease from other liver conditions.

Ursodeoxycholic acid is a medication that can slow down the progression of liver failure in patients with primary biliary cholangitis (PBC). PBC is characterized by symptoms such as general itching, elevated levels of alkaline phosphatase and direct hyperbilirubinemia, and high levels of anti-mitochondrial antibodies. Ursodeoxycholic acid is a synthetic secondary bile acid that reduces the synthesis of cholesterol and bile acids in the liver, which helps to reduce the total bile acid pool and prevent hepatotoxicity caused by the accumulation of bile acids.

Corticosteroids are commonly used to treat autoimmune hepatitis.

Etanercept is a medication that inhibits tumour necrosis factor and is used to treat conditions such as rheumatoid arthritis, psoriasis, psoriatic arthritis, and ankylosing spondylitis.

Lamivudine is a nucleoside analogue that can inhibit viral reverse transcriptase and is used to treat infections caused by HIV or HBV.

Cholestyramine is a medication that binds to bile acids in the intestinal lumen, preventing their reabsorption. It is used to treat conditions such as hypercholesterolemia, pruritus, and diarrhea.

Differentiating Management Options for Gallstone Disease

Gallstone disease is a common condition that can present with a variety of symptoms. The management of this condition depends on the patient’s clinical presentation and the severity of their disease. Here are some differentiating management options for gallstone disease:

No Intervention Required:
If a patient presents with vague abdominal pain after taking codeine phosphate, it is important to exclude the possibility of a ruptured abdominal aortic aneurysm. However, if the patient has asymptomatic gallstone disease, no intervention is required, and they can be managed expectantly.

Elective Cholecystectomy:
For patients with asymptomatic gallstone disease, prophylactic cholecystectomy is not indicated unless there is a high risk of life-threatening complications. However, if the patient has symptomatic gallstone disease, such as colicky right upper quadrant pain, elective cholecystectomy may be necessary.

Endoscopic Retrograde Cholangiopancreatography (ERCP):
ERCP is indicated for patients with common duct bile stones or if stenting of benign or malignant strictures is required. However, if the patient has asymptomatic gallstone disease, ERCP is not necessary.

Immediate Cholecystectomy:
If a patient has acute cholecystitis (AC), immediate cholecystectomy is indicated. AC typically presents with right upper quadrant pain and elevated inflammatory markers.

Percutaneous Cholecystectomy:
For critically unwell patients who are poor surgical candidates, percutaneous cholecystectomy may be necessary. This procedure involves the image-guided placement of a drainage catheter into the gallbladder lumen to stabilize the patient before a more controlled surgical approach can be taken in the future.

In summary, the management of gallstone disease depends on the patient’s clinical presentation and the severity of their disease. It is important to differentiate between the different management options to provide the best possible care for each patient.

Autoimmune Liver Diseases: Differentiating PBC, PSC, and AIH

Autoimmune liver diseases, including primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis (AIH), can present with non-specific symptoms and insidious onset. However, certain demographic and serological markers can help differentiate between them.

PBC is characterized by chronic granulomatous inflammation of small intrahepatic bile ducts, leading to progressive cholestasis, cirrhosis, and portal hypertension. It is often diagnosed incidentally or presents with lethargy and pruritus. AMA M2 subtype positivity is highly specific for PBC, and treatment involves cholestyramine for itching and ursodeoxycholic acid. Liver transplantation is the only curative treatment.

PSC is a disorder of unknown etiology characterized by non-malignant, non-bacterial inflammation, fibrosis, and strictures of the intra- and extrahepatic biliary tree. It is more common in men and frequently found in patients with ulcerative colitis. AMA is negative, and diagnosis is based on MRCP or ERCP showing a characteristic beaded appearance of the biliary tree.

AIH is a disorder of unknown cause characterized by autoantibodies directed against hepatocyte surface antigens. It can present acutely with signs of fulminant autoimmune disease or insidiously. There are three subtypes with slightly different demographic distributions and prognoses, and serological markers such as ASMA, anti-LKM, and anti-soluble liver antigen antibodies can help differentiate them.

A hepatitis screen is negative in this case, ruling out hepatitis C. A pancreatic head tumor would present with markedly elevated bilirubin and a normal autoimmune screen.

Angiodysplasia

Angiodysplasia is a condition where previously healthy blood vessels degenerate, commonly found in the caecum and proximal ascending colon. The majority of angiodysplasias, around 77%, are located in these areas. Symptoms of angiodysplasia include maroon-coloured stool, melaena, haematochezia, and haematemesis. Bleeding is usually low-grade, but in some cases, around 15%, it can be massive. However, bleeding stops spontaneously in over 90% of cases.

Radionuclide scanning using technetium Tc99 labelled red blood cells can help detect and locate active bleeding from angiodysplasia, even at low rates of 0.1 ml/min. However, the intermittent nature of bleeding in angiodysplasia limits the usefulness of this method. For patients who are haemodynamically stable, a conservative approach is recommended as most bleeding angiodysplasias will stop on their own. Treatment is usually not necessary for asymptomatic patients who incidentally discover they have angiodysplasias.

Overall, angiodysplasia and its symptoms is important for early detection and management.

Alcoholic Liver Disease: Understanding the Pathophysiology

Alcoholic liver disease is a spectrum of liver disease that can lead to serious complications if left untreated. Understanding the pathophysiology of this condition is crucial in managing and preventing its progression.

The primary pathological process in alcoholic liver disease is fibrosis, which results in the disruption of normal liver architecture. This leads to distortion of hepatic vasculature, increased intrahepatic resistance, and portal hypertension. Cirrhosis of the liver is an irreversible process and can lead to liver failure if the patient continues to drink alcohol.

Deposition of excess lipids in hepatocytes is another common feature of alcoholic liver disease. This causes steatohepatitis and is reversible. It is associated with metabolic syndrome.

Portal hypertension is a complication of alcoholic cirrhosis due to increased vascular resistance within the liver. It can result in oesophageal varices, which, if ruptured, can cause a large upper gastrointestinal bleed.

Contrary to popular belief, alcohol exposure does not cause cell death directly.

Sclerosis of the intra- and extrahepatic bile ducts is a pathophysiological process in primary sclerosing cholangitis. It causes inflammation, fibrosis, and strictures of the bile ducts and has a strong association with ulcerative colitis.

In summary, understanding the pathophysiology of alcoholic liver disease is crucial in managing and preventing its progression. Fibrosis, lipid deposition, portal hypertension, and bile duct sclerosis are all important features of this condition.